Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections
Clinical trial NCT03038971 · TERMINATED
Trial details
- NCT number
- NCT03038971
- Sponsor
- Woodmont Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2017-04-29
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.